UBS Group’s Arrowhead Research ARWR Stock Holding History

UBS Group’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-11,800	Closed	-$87K	–	8775
2014 Q4	$87K	Buy	+11,800	New	+$80.3K	﹤0.01%	5837

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

UBS Group's ARWR Position: Q1 2026 in Review

UBS Group increased its Arrowhead Research (ARWR) stake by 35% in Q1 2026, buying an estimated $22.1M and bringing the position to 1,336,271 shares worth $83.8M. The position accounts for 0.01% of the portfolio, ranked #1192.

UBS Group first reported a position in ARWR in Q4 2014 and has held it in 46 quarters since. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

UBS Group held 1,336,271 shares of Arrowhead Research worth $83.8M as of Q1 2026.
UBS Group bought 348,984 Arrowhead Research shares in Q1 2026, an estimated $22.1M.
Arrowhead Research made up 0.01% of UBS Group's portfolio in Q1 2026, its #1192 holding.
UBS Group first reported a position in Arrowhead Research in Q4 2014 and has held it in 46 quarters since.
436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.